Minute Insight: Quest Diagnostics To Acquire Haystack Oncology For $300M In Cash

27 Apr 2023

• By Marion Webb

Quest Diagnostics will buy liquid biopsy start-up Haystack Oncology for a total of $450m with plans to launch a cancer-detection test in 2024.

Minute Insight — • Source: Informa/Alamy

More from Minute Insights

More from Medtech Insight